Esper Bionics

Overview
News
Wearable Tech?
Product stageSegments
Go-to-Market
?
Wearable medical devices
?

Esper Bionics' flagship product is the Esper Hand, a self-learning robotic prosthetic hand for individuals with upper limb differences. Launched in 2022, the lightweight Esper Hand features five movable fingers that can perform various tasks with human-like dexterity, from opening bottles to using tools. It employs cutting-edge technologies like artificial intelligence (AI), machine learning, and electromyography to detect the user's muscle movements and brain impulses. As the user interacts with the Esper Hand, it analyzes data to understand usage patterns, predict intended movements, and suggest appropriate grips.

The accompanying Esper Platform, a cloud-based software solution, further enhances the user experience by gathering data from connected devices to refine control algorithms continually. This data-driven approach enables the prosthetic to become increasingly intuitive over time, customized to each individual's needs.

Weighing just 380 grams, the Esper Hand is crafted from aerospace-grade materials and ergonomically designed for comfort and functionality, available in multiple sizes and colors. Its modular construction allows easy maintenance and replacement of components.

In addition to the Esper Hand, the company offers Esper Control, a non-invasive brain-computer interface that translates neural signals into prosthetic movements. Esper Bionics sees its current product line as vital stepping stones toward developing sophisticated electronic implants that could significantly enhance human capabilities in the future.


Sources

Disclaimer: This company profile has been generated using data obtained through automated web searches and advanced generative AI technology. While we strive to ensure the accuracy and reliability of our sources, auto-generated information could be outdated or inaccurate and should be verified independently.
HQ location:
New York NY USA
Founded year:
2019
Employees:
11-50
IPO status:
Private
Total funding:
USD 5.2 mn
Last Funding:
USD 5.0 mn (Series Unknown; Jun 2024)
Last valuation:
-
Key competitors
Filter by the segments to which the disruptor belongs
All Segmentsexpand
 
Loading...
Loading...
Loading...
Loading...
Product Overview
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Product Metrics
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Company profile
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
-
Loading...
Loading...
Loading...
Loading...
Funding data are powered by Crunchbase
arrow
menuarrow
Click here to learn more
Get a demo

By using this site, you agree to allow SPEEDA Edge and our partners to use cookies for analytics and personalization. Visit our privacy policy for more information about our data collection practices.